Net sales for Q1 2026 were $6.85 million, a 5.4% decrease from $7.25 million in Q1 2025. Reported a net loss of $362,015, or $0.37 per share, compared to a net income of $401,022, or $0.42 per share, in the prior year period. Gross profit fell 42.2% to $958,459, impacted by lower sales volumes and unfavorable product mix. Operating loss for the quarter was $381,591, compared to an operating income of $409,694 in Q1 2025. Cash and cash equivalents stood at $1.45 million as of March 31, 2026. Management identified a material weakness in internal controls related to inventory review.